Bright Minds Biosciences Inc.

DRUG chart

Bright Minds Biosciences Inc. news

• Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock

  CNBC · Oct 26, 12:56 PM EDT

• Lunit surges in the 13% range on collaboration with U.S. Summit to develop next-generation cancer drug [Stock NOW]

  파이낸셜뉴스 · Oct 25, 8:15 PM EDT

• astrazeneca acquired rights to cspc experimental weight-loss drugs for billions

  BusinessWorld Online · Oct 25, 4:41 PM EDT

• Bright Minds Biosciences (DRUG) Edges Lower to $52.48, Holding Above Key Support - TICK Divergence

  https://www.dars.gov.et/ · Oct 24, 1:46 PM EDT

• Bright Minds Biosciences Inc. (DRUG) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 23, 5:52 PM EDT

• Moderna Stock Cools After Cancer Vaccine Data Leak

  Schaeffer's Investment Research · Oct 23, 8:57 AM EDT

• 3 Canadian Biotech Stocks With Up To 39% Net Margins

  Yahoo Finance · Oct 22, 12:14 PM EDT

• Top 3 Canadian Biotech Stocks To Watch In October 2026

  Simply Wall Street · Oct 22, 9:49 AM EDT

• Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 5.9% - Here's What Happened

  MarketBeat · Oct 21, 3:29 PM EDT

• Bright Minds Biosciences Inc. (CN:DRUG) Gains Momentum as Investor Optimism Supports Upside Potential

  kalkine.ca · Oct 21, 3:05 AM EDT

• 3 Canadian Biotech Stocks Trading Up To 93% Below Fair Value

  Yahoo Finance · Oct 15, 6:10 AM EDT

• Bright Minds Biosciences And 2 More Canadian Biotech Stocks

  Yahoo Finance · Oct 8, 5:09 AM EDT

Bright Minds Biosciences Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-10-02
• 6-KFORM 6-K2026-10-01
• 6-KFORM 6-K2026-08-17
• 6-KFORM 6-K2026-06-03
• 6-KFORM 6-K2026-06-02
• 6-KReport (foreign issuer)2026-05-28
• 6-KFORM 6-K2026-05-20
• 6-KFORM 6-K2026-02-13
• 6-KFORM 6-K2026-01-09
• 6-KFORM 6-K2026-01-09
• 6-KReport (foreign issuer)2026-01-08
• 6-KFORM 6-K2026-01-07

About Bright Minds Biosciences Inc.

Ticker

DRUG (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Chicago, IL

Incorporated in

British Columbia, Canada

Fiscal year end

September 30

SEC CIK

1827401

Frequently asked questions